Skip Navigation

Cardiovascular Research 2005 67(3):459-466; doi:10.1016/j.cardiores.2005.01.017
This Article
Right arrow Full Text Freely available
Right arrow FREE Full Text (PDF) Freely available
Right arrow E-letters: Submit a response
Right arrow Alert me when this article is cited
Right arrow Alert me when E-letters are posted
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to My Personal Archive
Right arrow Download to citation manager
Right arrowRequest Permissions
Right arrow Disclaimer
Google Scholar
Right arrow Articles by Smits, J. P.P.
Right arrow Articles by Wilde, A. A.M.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Smits, J. P.P.
Right arrow Articles by Wilde, A. A.M.
Social Bookmarking
 Add to CiteULike   Add to Connotea   Add to Del.icio.us  
What's this?

Copyright © 2005, European Society of Cardiology

Substitution of a conserved alanine in the domain IIIS4–S5 linker of the cardiac sodium channel causes long QT syndrome

Jeroen P.P. Smitsa, Marieke W. Veldkampa, Connie R. Bezzinaa, Zahir A. Bhuiyana,b, Horst Wedekindc,d, Eric Schulze-Bahrc,d and Arthur A.M. Wildea,*

aExperimental and Molecular Cardiology Group, Academic Medical Center, University of Amsterdam, Amsterdam, The Netherlands
bDepartment of Clinical Genetics, Academic Medical Center, University of Amsterdam, Amsterdam, The Netherlands
cDepartment of Cardiology and Angiology, University of Münster, Münster, Germany
dDepartment of Molecular Cardiology, Institute for Arteriosclerosis Research of the University of Münster, Münster, Germany

* Corresponding author. Department of Clinical and Experimental Cardiology, Academic Medical Center, University of Amsterdam, Room M-0-107, Meibergdreef 9, 1105 AZ Amsterdam, PO Box 22700, 1100 DE Amsterdam, The Netherlands. Tel.: +31 20 5663265; fax: +31 20 6975458. Email address: a.a.wilde{at}amc.uva.nl

Objective: Congenital long QT syndrome type 3 (LQT3) is an inherited cardiac arrhythmia disorder due to mutations in the cardiac sodium channel gene, SCN5A. Although most LQT3 mutations cause a persistent sodium current, increasing diversity in the disease mechanism is shown. Here we present the electrophysiological properties of the A1330T sodium channel mutation (DIIIS4–S5 linker). Like the A1330P, LQT3 mutation, A1330T, causes LQT3 in the absence of a persistent current.

Methods: A1330T, A1330P and wild-type sodium channels were expressed in HEK-293 cells and characterized using the whole-cell configuration of the patch-clamp technique.

Results: The A1330T mutation shifts positively the voltage-dependence of inactivation and speeds recovery from inactivation. Measurements of sodium window (INa, window) currents revealed a positive shift of the INa, window voltage range for both 1330 mutants, with in addition an increase in INa, window magnitude for the A1330P mutant. Action potential (AP) clamp experiments revealed that these changes in INa, window properties cause an increased inward current during the initial part of phase 4 repolarization of the AP.

Conclusions: Our findings indicate that the alanine at position 1330 in the DIIIS4–S5 linker of the cardiac sodium channel has a role in channel fast inactivation. Substitution by a threonine shifts the voltage range of INa, window activity to more positive potentials. Here the counter-acting effect of outward K+ current is reduced and may delay AP repolarization, explaining the LQT3 phenotype.

KEYWORDS Long QT syndrome; Ion channel; Action potential


Time for primary review 21 days


Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us    What's this?


This article has been cited by other articles:


Home page
J. Physiol.Home page
B. W. Jarecki, P. L. Sheets, J. O. Jackson II, and T. R. Cummins
Paroxysmal extreme pain disorder mutations within the D3/S4-S5 linker of Nav1.7 cause moderate destabilization of fast inactivation
J. Physiol., September 1, 2008; 586(17): 4137 - 4153.
[Abstract] [Full Text] [PDF]


Home page
Cardiovasc ResHome page
S. Casini, H. L. Tan, Z. A. Bhuiyan, C. R. Bezzina, P. Barnett, E. Cerbai, A. Mugelli, A. A.M. Wilde, and M. W. Veldkamp
Characterization of a novel SCN5A mutation associated with Brugada syndrome reveals involvement of DIIIS4-S5 linker in slow inactivation
Cardiovasc Res, December 1, 2007; 76(3): 418 - 429.
[Abstract] [Full Text] [PDF]


Home page
CirculationHome page
Y. Ruan, N. Liu, R. Bloise, C. Napolitano, and S. G. Priori
Gating Properties of SCN5A Mutations and the Response to Mexiletine in Long-QT Syndrome Type 3 Patients
Circulation, September 4, 2007; 116(10): 1137 - 1144.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
A. Lampert, S. D. Dib-Hajj, L. Tyrrell, and S. G. Waxman
Size Matters: Erythromelalgia Mutation S241T in Nav1.7 Alters Channel Gating
J. Biol. Chem., November 24, 2006; 281(47): 36029 - 36035.
[Abstract] [Full Text] [PDF]


Home page
J. Physiol.Home page
G. Berecki, J. G. Zegers, Z. A. Bhuiyan, A. O. Verkerk, R. Wilders, and A. C. G. van Ginneken
Long-QT syndrome-related sodium channel mutations probed by the dynamic action potential clamp technique
J. Physiol., January 15, 2006; 570(2): 237 - 250.
[Abstract] [Full Text] [PDF]


Home page
Cardiovasc ResHome page
C. R. Bezzina, A. A.M. Wilde, and D. M. Roden
The molecular genetics of arrhythmias
Cardiovasc Res, August 15, 2005; 67(3): 343 - 346.
[Full Text] [PDF]



Disclaimer: Please note that abstracts for content published before 1996 were created through digital scanning and may therefore not exactly replicate the text of the original print issues. All efforts have been made to ensure accuracy, but the Publisher will not be held responsible for any remaining inaccuracies. If you require any further clarification, please contact our Customer Services Department.